Literature DB >> 9287174

Immunobiology of Helicobacter pylori infection.

J L Telford1, A Covacci, R Rappuoli, P Chiara.   

Abstract

Helicobacter pylori is a 'slow' bacterial pathogen. While infection is usually acquired early in life, only decades later does severe pathology appear. During this long period of incubation, the host mounts a vigorous immune response against H. pylori which fails to resolve the infection and may in fact contribute to the severity of the disease. In the past year, evidence has accumulated indicating a role for a polarized T helper 1 cell response in the gastric pathology induced by H. pylori. Furthermore, a pathogenicity island in type I H. pylori strains has been shown to be responsible for H. pylori induced inflammation. Recent advances in animal models have provided the rationale for entering into human clinical trials of an H. pylori vaccine

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287174     DOI: 10.1016/s0952-7915(97)80101-x

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration.

Authors:  M C Gunn; J C Stephens; J A Stewart; B J Rathbone; K P West
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

3.  Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.

Authors:  Dirk Bumann; Sevil Aksu; Meike Wendland; Katharina Janek; Uschi Zimny-Arndt; Nicolas Sabarth; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

4.  Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol.

Authors:  M de Bernard; D Burroni; E Papini; R Rappuoli; J Telford; C Montecucco
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Celecoxib inhibits Helicobacter pylori colonization-related factors.

Authors:  Jing Wang; Wei-Hong Wang; Jiang Li; Fang-Xun Liu
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

6.  Deletion of cagA gene of Helicobacter pylori by PCR products.

Authors:  Xun Zeng; Li-Hua He; Yan Yin; Mao-Jun Zhang; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

Review 7.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

9.  CD4+ and CD8+ T cell responses in Helicobacter pylori-infected individuals.

Authors:  M Quiding-Järbrink; B S Lundin; H Lönroth; A M Svennerholm
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

10.  Reactions from rat gastric mucosa during one year of Helicobacter pylori infection.

Authors:  H Li; E M Andersson; H F Helander
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.